Tankyevych, O.; Trousset, F.; Latappy, C.; Berraho, M.; Dutilh, J.; Tasu, J.P.; Lamour, C.; Cheze Le Rest, C.
Development of Radiomic-Based Model to Predict Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy. Cancers 2022, 14, 5931.
https://doi.org/10.3390/cancers14235931
AMA Style
Tankyevych O, Trousset F, Latappy C, Berraho M, Dutilh J, Tasu JP, Lamour C, Cheze Le Rest C.
Development of Radiomic-Based Model to Predict Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy. Cancers. 2022; 14(23):5931.
https://doi.org/10.3390/cancers14235931
Chicago/Turabian Style
Tankyevych, Olena, Flora Trousset, Claire Latappy, Moran Berraho, Julien Dutilh, Jean Pierre Tasu, Corinne Lamour, and Catherine Cheze Le Rest.
2022. "Development of Radiomic-Based Model to Predict Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy" Cancers 14, no. 23: 5931.
https://doi.org/10.3390/cancers14235931
APA Style
Tankyevych, O., Trousset, F., Latappy, C., Berraho, M., Dutilh, J., Tasu, J. P., Lamour, C., & Cheze Le Rest, C.
(2022). Development of Radiomic-Based Model to Predict Clinical Outcomes in Non-Small Cell Lung Cancer Patients Treated with Immunotherapy. Cancers, 14(23), 5931.
https://doi.org/10.3390/cancers14235931